CVS - CVS Health Corporation

NYSE - NYSE Delayed price. Currency in USD
76.02
-0.03 (-0.04%)
At close: 4:00PM EST
Stock chart is not supported by your current browser
Previous close76.05
Open76.11
Bid75.99 x 800
Ask76.10 x 1400
Day's range75.83 - 76.44
52-week range51.72 - 77.03
Volume5,123,530
Avg. volume6,584,901
Market cap98.899B
Beta (5Y monthly)0.87
PE ratio (TTM)21.41
EPS (TTM)3.55
Earnings date11 Feb 2020
Forward dividend & yield2.00 (2.63%)
Ex-dividend date20 Jan 2020
1y target est81.67
  • Should CVS Health Corporation (NYSE:CVS) Be Part Of Your Dividend Portfolio?
    Simply Wall St.

    Should CVS Health Corporation (NYSE:CVS) Be Part Of Your Dividend Portfolio?

    Dividend paying stocks like CVS Health Corporation (NYSE:CVS) tend to be popular with investors, and for good reason...

  • Why CVS Health (CVS) Could Beat Earnings Estimates Again
    Zacks

    Why CVS Health (CVS) Could Beat Earnings Estimates Again

    CVS Health (CVS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

  • The Zacks Analyst Blog Highlights: UnitedHealth, CVS Health, Morgan Stanley, Charles Schwab and Uber Technologies
    Zacks

    The Zacks Analyst Blog Highlights: UnitedHealth, CVS Health, Morgan Stanley, Charles Schwab and Uber Technologies

    The Zacks Analyst Blog Highlights: UnitedHealth, CVS Health, Morgan Stanley, Charles Schwab and Uber Technologies

  • CVS Health's Selling Seasons Strong, Omnicare Arm Upsets
    Zacks

    CVS Health's Selling Seasons Strong, Omnicare Arm Upsets

    CVS Health's (CVS) 2020 PBM selling season remains strong with gross new business and net new business wins.

  • CVS Health (CVS) Outpaces Stock Market Gains: What You Should Know
    Zacks

    CVS Health (CVS) Outpaces Stock Market Gains: What You Should Know

    In the latest trading session, CVS Health (CVS) closed at $72.76, marking a +0.9% move from the previous day.

  • Top Research Reports for UnitedHealth, CVS & Morgan Stanley
    Zacks

    Top Research Reports for UnitedHealth, CVS & Morgan Stanley

    Top Research Reports for UnitedHealth, CVS & Morgan Stanley

  • Cigna-Express Scripts bets on digital care as the future of health
    Yahoo Finance

    Cigna-Express Scripts bets on digital care as the future of health

    Cigna-ESI remain focused on virtual care in 2020.

  • SmileDirectClub invades 3,800 Walmart stores with these new products
    Yahoo Finance

    SmileDirectClub invades 3,800 Walmart stores with these new products

    SmileDirectClub scores a big deal with Walmart.

  • CVS Health Corporation (NYSE:CVS) Might Not Be A Great Investment
    Simply Wall St.

    CVS Health Corporation (NYSE:CVS) Might Not Be A Great Investment

    Today we'll evaluate CVS Health Corporation (NYSE:CVS) to determine whether it could have potential as an investment...

  • CVS Health (CVS) Gains As Market Dips: What You Should Know
    Zacks

    CVS Health (CVS) Gains As Market Dips: What You Should Know

    In the latest trading session, CVS Health (CVS) closed at $74.51, marking a +0.17% move from the previous day.

  • Rite Aid (RAD) Earnings Surpass Estimates in Q3, Stock Up
    Zacks

    Rite Aid (RAD) Earnings Surpass Estimates in Q3, Stock Up

    Rite Aid (RAD) posts robust results in third-quarter fiscal 2020. Notably, the bottom line benefits from higher adjusted EBITDA in the quarter.

  • Investing.com

    Breaking: Justice Dept. Sues CVS Over Medicare Prescriptions

    Investing.com - The U.S. federal government filed a lawsuit against CVS Health (NYSE:CVS) and the company’s Omnicare unit Tuesday for fraudulently billing Medicare, sending shares lower.

  • Walgreens is the Worst Dow Stock Now, Will 2020 Be Different?
    Zacks

    Walgreens is the Worst Dow Stock Now, Will 2020 Be Different?

    Despite the dismal performance in recent times, Walgreens (WBA) has chances to bounce back in 2020.

  • HMO Industry Outlook: Multiple Levers to Drive Growth
    Zacks

    HMO Industry Outlook: Multiple Levers to Drive Growth

    HMO Industry Outlook: Multiple Levers to Drive Growth

  • Target CEO: We are taking 'enormous' market share in cosmetics
    Yahoo Finance

    Target CEO: We are taking 'enormous' market share in cosmetics

    Target CEO Brian Cornell talks with Yahoo Finance about the company's success down the cosmetics aisle.

  • CVS Health Rides on Aetna Prospects, Strong Selling Season
    Zacks

    CVS Health Rides on Aetna Prospects, Strong Selling Season

    CVS Health's (CVS) 2020 PBM selling season is approaching closure and the 2021 selling season is ongoing.

  • The Zacks Analyst Blog Highlights: Toyota, CVS, 3M, Gilead and Goldman
    Zacks

    The Zacks Analyst Blog Highlights: Toyota, CVS, 3M, Gilead and Goldman

    The Zacks Analyst Blog Highlights: Toyota, CVS, 3M, Gilead and Goldman

  • Top Stock Reports for Toyota, CVS Health & 3M
    Zacks

    Top Stock Reports for Toyota, CVS Health & 3M

    Top Stock Reports for Toyota, CVS Health & 3M

  • UnitedHealth (UNH) to Buy Diplomat, Expand Pharmacy Services
    Zacks

    UnitedHealth (UNH) to Buy Diplomat, Expand Pharmacy Services

    UnitedHealth (UNH) inks an agreement to acquire Diplomat to expand its in-house pharmacy benefit management business.

  • Does CVS Health Corporation's (NYSE:CVS) P/E Ratio Signal A Buying Opportunity?
    Simply Wall St.

    Does CVS Health Corporation's (NYSE:CVS) P/E Ratio Signal A Buying Opportunity?

    This article is written for those who want to get better at using price to earnings ratios (P/E ratios). We'll look at...

  • Why Is CVS Health (CVS) Up 3.8% Since Last Earnings Report?
    Zacks

    Why Is CVS Health (CVS) Up 3.8% Since Last Earnings Report?

    CVS Health (CVS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

  • 20 businesses that died in the 2010s
    Yahoo Finance

    20 businesses that died in the 2010s

    Yahoo Finance takes a look back at some of the biggest corporate busts of the last decade.

  • Elizabeth Warren Wants to Spoil the Megamerger Party
    Bloomberg

    Elizabeth Warren Wants to Spoil the Megamerger Party

    (Bloomberg Opinion) -- The merger floodgates broke open five years ago, and now U.S. Senator Elizabeth Warren wants to close the hatch. Her proposed bill to substantially restrict big corporate tie-ups is more a presidential campaign statement than viable legislation — and it certainly won’t score her any more points with the Wall Street crowd — but she is calling attention to the maniacal pace of dealmaking in corporate America and the need to modernize antitrust laws that have permitted some recent problematic transactions.More than $7 trillion of takeovers of U.S. companies have been announced since this day in 2014 — 52,694 companies to be exact.(1) That compares with just $4.4 trillion of deals in the previous five-year period. The transactions grew over time as balance sheets flush with cash and income statements desperate for growth created a perfect storm, which more often than not was stoked by pliable regulators. The Walt Disney Co. acquired 21st Century Fox Inc.; Charter Communications Inc. bought Time Warner Cable Inc.; CVS Health Corp. took over Aetna Inc.; Marriott International Inc. merged with Starwood Hotels & Resorts Worldwide Inc.; and T-Mobile US Inc. is trying to buy Sprint Corp. Those are just some of the more recognizable names. Warren, one of the top-polling candidates heading into the Democratic primaries, wants to ban deals in which one company has annual revenue of more than $40 billion, or both businesses generate more than $15 billion in sales, according to a draft of the bill reviewed by Bloomberg News. (A notable exception would be companies facing insolvency.) That could effectively prevent every top airline, insurer, manufacturer, oil producer, retailer, technology platform and other conglomerates — perhaps even Warren Buffett’s M&A vehicle, Berkshire Hathaway Inc. — from making any acquisitions. It would sound the M&A death knell. The idea, however, is unlikely to gain broad support among lawmakers.Even so, it’s hard not to notice the rising drumbeat of politicians concerned about overreach by corporate giants, particularly those in the tech field. Senator Amy Klobuchar, another Democratic presidential candidate, plans to introduce separate antitrust legislation soon, Bloomberg News reported, citing a person familiar with the matter. (Michael Bloomberg, the founder and majority owner of Bloomberg LP, the parent of Bloomberg News and Bloomberg Opinion, is also campaigning for president.)For the Trump administration’s part, the U.S. Justice Department is already investigating whether tech giants — namely Apple Inc., Amazon.com Inc., Facebook Inc. and Google — are using their unchecked power to engage in harmful business practices. But as I wrote in July, if regulators are so concerned about protecting consumers from tech overreach, their glowing endorsement of T-Mobile’s takeover of Sprint is a funny way of showing it; it will shrink the U.S. wireless market from four to three major carriers and remove a company that’s helped to keep customer prices in check.Antitrust regulation under President Donald Trump has at times created questionable optics. Makan Delrahim, the Justice Department’s top antitrust enforcer, seemed to switch his stance on AT&T Inc.’s takeover of Time Warner Inc. as Trump railed against the deal. Time Warner was the parent of CNN, which Trump views as his personal nemesis. (I’ve argued that whatever the case, scrutiny of the megamerger was warranted considering the broad market power it gave to AT&T as media companies without such scale struggle to compete.) By comparison, Disney and Fox, which was controlled by Trump pal Rupert Murdoch, closed their megadeal with few regulatory hiccups. Warren has criticized other giant deals, such as the merger of SunTrust Banks Inc. and BB&T Corp. and the combination of seed makers Bayer AG and Monsanto Co. Given that they aren’t household names, though, most Americans are unfazed by or unaware of such deals, even though they may feel the effects later. Her bill would direct the government to take into account not just whether a merger will lead to higher prices but also what the impact might be on workers, privacy and industry innovation. To justify the cost of buying another large company, dealmakers tend to come up with ambitious estimates of synergies, a euphemism for layoffs. It’s clear that the meaning of “harm” needs to be expanded in the antitrust sense, and laws need to take a more holistic view of the potential consequences of M&A as the lines between industries continue to blur. The Big Tech factor also needs to be weighed, as some deals are being done in part to respond to companies like Amazon that are spreading their tentacles into new areas. On Wednesday, TV-network operators CBS Corp. and Viacom Inc. completed their own merger, a bid to cut costs and create more scale to compete against a new roster of even more powerful media giants: Amazon, Apple, AT&T and Disney. Even then, ViacomCBS Inc., as the merged entity is now called, may not be big enough, and so it may be only a matter of time before it gets swallowed. Warren’s overly broad proposal likely isn’t the answer. But Democrats do seem ready to at least try to rein in a market that’s gotten out of hand. For dealmakers, this may be last call at the M&A party.(1) Data compiled by Bloomberg as of Thursday morning. Excludes terminated deals.To contact the author of this story: Tara Lachapelle at tlachapelle@bloomberg.netTo contact the editor responsible for this story: Daniel Niemi at dniemi1@bloomberg.netThis column does not necessarily reflect the opinion of the editorial board or Bloomberg LP and its owners.Tara Lachapelle is a Bloomberg Opinion columnist covering the business of entertainment and telecommunications, as well as broader deals. She previously wrote an M&A column for Bloomberg News.For more articles like this, please visit us at bloomberg.com/opinion©2019 Bloomberg L.P.